Annual CAPEX
$1.46 M
-$513.00 K-25.95%
31 December 2023
Summary:
Pharming Group NV annual capital expenditures is currently $1.46 million, with the most recent change of -$513.00 thousand (-25.95%) on 31 December 2023. During the last 3 years, it has fallen by -$13.84 million (-90.43%). PHAR annual CAPEX is now -94.25% below its all-time high of $25.45 million, reached on 31 December 2019.PHAR CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CAPEX
$366.00 K
+$152.00 K+71.03%
30 September 2024
Summary:
Pharming Group NV quarterly capital expenditures is currently $366.00 thousand, with the most recent change of +$152.00 thousand (+71.03%) on 30 September 2024. Over the past year, it has increased by +$219.00 thousand (+148.98%). PHAR quarterly CAPEX is now -98.19% below its all-time high of $20.19 million, reached on 30 September 2019.PHAR Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CAPEX
$991.00 K
+$219.00 K+28.37%
30 September 2024
Summary:
Pharming Group NV TTM capital expenditures is currently $991.00 thousand, with the most recent change of +$219.00 thousand (+28.37%) on 30 September 2024. Over the past year, it has dropped by -$457.00 thousand (-31.56%). PHAR TTM CAPEX is now -97.07% below its all-time high of $33.83 million, reached on 30 June 2020.PHAR TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PHAR CAPEX Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -25.9% | +149.0% | -31.6% |
| 3 y3 years | -90.4% | -87.2% | -92.9% |
| 5 y5 years | -66.0% | -98.2% | -95.5% |
PHAR CAPEX High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -91.2% | at low | -94.0% | +357.5% | -94.1% | +28.4% |
| 5 y | 5 years | -94.3% | at low | -98.2% | +357.5% | -97.1% | +28.4% |
| alltime | all time | -94.3% | +4948.3% | -98.2% | +282.4% | -97.1% | +3317.2% |
Pharming Group NV CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $366.00 K(+71.0%) | $991.00 K(+28.4%) |
| June 2024 | - | $214.00 K(+167.5%) | $772.00 K(-41.9%) |
| Mar 2024 | - | $80.00 K(-75.8%) | $1.33 M(-9.2%) |
| Dec 2023 | $1.46 M(-25.9%) | $331.00 K(+125.2%) | $1.46 M(+1.1%) |
| Sept 2023 | - | $147.00 K(-80.9%) | $1.45 M(+3.1%) |
| June 2023 | - | $771.00 K(+258.6%) | $1.41 M(-22.7%) |
| Mar 2023 | - | $215.00 K(-31.7%) | $1.82 M(-8.1%) |
| Dec 2022 | $1.98 M(-88.2%) | $315.00 K(+202.9%) | $1.98 M(-74.6%) |
| Sept 2022 | - | $104.00 K(-91.2%) | $7.79 M(-26.2%) |
| June 2022 | - | $1.18 M(+215.5%) | $10.55 M(-25.3%) |
| Mar 2022 | - | $375.00 K(-93.9%) | $14.13 M(-15.5%) |
| Dec 2021 | $16.72 M(+9.3%) | $6.13 M(+114.0%) | $16.72 M(+19.7%) |
| Sept 2021 | - | $2.86 M(-39.9%) | $13.97 M(+10.2%) |
| June 2021 | - | $4.76 M(+60.7%) | $12.67 M(+11.9%) |
| Mar 2021 | - | $2.96 M(-12.3%) | $11.33 M(-26.0%) |
| Dec 2020 | $15.30 M(-39.9%) | $3.38 M(+115.0%) | $15.30 M(+0.6%) |
| Sept 2020 | - | $1.57 M(-54.0%) | $15.21 M(-55.0%) |
| June 2020 | - | $3.42 M(-50.7%) | $33.83 M(+5.7%) |
| Mar 2020 | - | $6.93 M(+110.7%) | $32.00 M(+25.7%) |
| Dec 2019 | $25.45 M(+490.3%) | $3.29 M(-83.7%) | $25.45 M(+15.9%) |
| Sept 2019 | - | $20.19 M(+1169.7%) | $21.96 M(+454.9%) |
| June 2019 | - | $1.59 M(+312.7%) | $3.96 M(+9.2%) |
| Mar 2019 | - | $385.20 K(-292.0%) | $3.62 M(-15.9%) |
| Dec 2018 | $4.31 M(-40.6%) | -$200.60 K(-109.2%) | $4.31 M(-30.9%) |
| Sept 2018 | - | $2.18 M(+73.8%) | $6.24 M(-13.7%) |
| June 2018 | - | $1.26 M(+17.1%) | $7.23 M(-2.7%) |
| Mar 2018 | - | $1.07 M(-37.8%) | $7.43 M(+2.5%) |
| Dec 2017 | $7.25 M(+355.5%) | $1.73 M(-45.7%) | $7.25 M(+19.2%) |
| Sept 2017 | - | $3.18 M(+117.6%) | $6.08 M(+95.9%) |
| June 2017 | - | $1.46 M(+63.8%) | $3.11 M(+40.5%) |
| Mar 2017 | - | $891.20 K(+59.7%) | $2.21 M(+38.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2016 | $1.59 M(+62.2%) | $557.90 K(+181.9%) | $1.59 M(+25.7%) |
| Sept 2016 | - | $197.90 K(-64.9%) | $1.27 M(-6.9%) |
| June 2016 | - | $564.50 K(+107.5%) | $1.36 M(+14.1%) |
| Mar 2016 | - | $272.00 K(+17.0%) | $1.19 M(+21.4%) |
| Dec 2015 | $981.80 K(+424.2%) | $232.40 K(-20.4%) | $981.80 K(+31.0%) |
| Sept 2015 | - | $291.80 K(-26.3%) | $749.40 K(+63.8%) |
| June 2015 | - | $395.90 K(+541.7%) | $457.60 K(+641.7%) |
| Mar 2015 | - | $61.70 K(+8714.3%) | $61.70 K(+112.8%) |
| Dec 2014 | $187.30 K(+545.9%) | - | - |
| Dec 2013 | $29.00 K(-96.4%) | $700.00(-30.0%) | $29.00 K(-45.5%) |
| Sept 2013 | - | $1000.00(-96.3%) | $53.20 K(-52.8%) |
| June 2013 | - | $27.30 K(+9.6%) | $112.60 K(-86.1%) |
| Dec 2012 | $812.00 K(-40.8%) | $24.90 K(-58.8%) | $812.00 K(-38.9%) |
| Sept 2012 | - | $60.40 K(-89.3%) | $1.33 M(+2.7%) |
| June 2012 | - | $565.30 K(+250.2%) | $1.29 M(-3.5%) |
| Mar 2012 | - | $161.40 K(-70.3%) | $1.34 M(-2.1%) |
| Dec 2011 | $1.37 M(+13.4%) | $542.80 K(+2071.2%) | $1.37 M(+23.5%) |
| Sept 2011 | - | $25.00 K(-95.9%) | $1.11 M(-43.6%) |
| June 2011 | - | $612.90 K(+221.6%) | $1.97 M(+44.3%) |
| Mar 2011 | - | $190.60 K(-32.5%) | $1.37 M(+13.0%) |
| Dec 2010 | $1.21 M(+177.5%) | $282.20 K(-68.1%) | $1.21 M(+33.7%) |
| Sept 2010 | - | $885.30 K(>+9900.0%) | $904.00 K(+695.1%) |
| June 2010 | - | $7900.00(-76.5%) | $113.70 K(-69.1%) |
| Mar 2010 | - | $33.60 K(-247.4%) | $368.30 K(-15.4%) |
| Dec 2009 | $435.60 K(-61.6%) | -$22.80 K(-124.0%) | $435.50 K(-5.0%) |
| Sept 2009 | - | $95.00 K(-63.8%) | $458.30 K(+26.1%) |
| June 2009 | - | $262.50 K(+160.4%) | $363.30 K(+260.4%) |
| Mar 2009 | - | $100.80 K | $100.80 K |
| Dec 2008 | $1.13 M(+15.8%) | - | - |
| Dec 2007 | $978.30 K(-76.5%) | - | - |
| Dec 2006 | $4.16 M(+308.8%) | - | - |
| Dec 2005 | $1.02 M | - | - |
FAQ
- What is Pharming Group NV annual capital expenditures?
- What is the all time high annual CAPEX for Pharming Group NV?
- What is Pharming Group NV annual CAPEX year-on-year change?
- What is Pharming Group NV quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Pharming Group NV?
- What is Pharming Group NV quarterly CAPEX year-on-year change?
- What is Pharming Group NV TTM capital expenditures?
- What is the all time high TTM CAPEX for Pharming Group NV?
- What is Pharming Group NV TTM CAPEX year-on-year change?
What is Pharming Group NV annual capital expenditures?
The current annual CAPEX of PHAR is $1.46 M
What is the all time high annual CAPEX for Pharming Group NV?
Pharming Group NV all-time high annual capital expenditures is $25.45 M
What is Pharming Group NV annual CAPEX year-on-year change?
Over the past year, PHAR annual capital expenditures has changed by -$513.00 K (-25.95%)
What is Pharming Group NV quarterly capital expenditures?
The current quarterly CAPEX of PHAR is $366.00 K
What is the all time high quarterly CAPEX for Pharming Group NV?
Pharming Group NV all-time high quarterly capital expenditures is $20.19 M
What is Pharming Group NV quarterly CAPEX year-on-year change?
Over the past year, PHAR quarterly capital expenditures has changed by +$219.00 K (+148.98%)
What is Pharming Group NV TTM capital expenditures?
The current TTM CAPEX of PHAR is $991.00 K
What is the all time high TTM CAPEX for Pharming Group NV?
Pharming Group NV all-time high TTM capital expenditures is $33.83 M
What is Pharming Group NV TTM CAPEX year-on-year change?
Over the past year, PHAR TTM capital expenditures has changed by -$457.00 K (-31.56%)